Kaposin-B Enhances the PROX1 mRNA Stability during Lymphatic Reprogramming of Vascular Endothelial Cells by Kaposi's Sarcoma Herpes Virus
Kaposi's sarcoma (KS) is the most common cancer among HIV-positive patients. Histogenetic origin of KS has long been elusive due to a mixed expression of both blood and lymphatic endothelial markers in KS tumor cells. However, we and others discovered that Kaposi's sarcoma herpes virus (KSHV) induces lymphatic reprogramming of blood vascular endothelial cells by upregulating PROX1, which functions as the master regulator for lymphatic endothelial differentiation. Here, we demonstrate that the KSHV latent gene kaposin-B enhances the PROX1 mRNA stability and plays an important role in KSHV-mediated PROX1 upregulation. We found that PROX1 mRNA contains a canonical AU-rich element (ARE) in its 3′-untranslated region that promotes PROX1 mRNA turnover and that kaposin-B stimulates cytoplasmic accumulation of the ARE-binding protein HuR through activation of the p38/MK2 pathway. Moreover, HuR binds to and stabilizes PROX1 mRNA through its ARE and is necessary for KSHV-mediated PROX1 mRNA stabilization. Together, our study demonstrates that kaposin-B plays a key role in PROX1 upregulation during lymphatic reprogramming of blood vascular endothelial cells by KSHV.
Vyšlo v časopise:
Kaposin-B Enhances the PROX1 mRNA Stability during Lymphatic Reprogramming of Vascular Endothelial Cells by Kaposi's Sarcoma Herpes Virus. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001046
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001046
Souhrn
Kaposi's sarcoma (KS) is the most common cancer among HIV-positive patients. Histogenetic origin of KS has long been elusive due to a mixed expression of both blood and lymphatic endothelial markers in KS tumor cells. However, we and others discovered that Kaposi's sarcoma herpes virus (KSHV) induces lymphatic reprogramming of blood vascular endothelial cells by upregulating PROX1, which functions as the master regulator for lymphatic endothelial differentiation. Here, we demonstrate that the KSHV latent gene kaposin-B enhances the PROX1 mRNA stability and plays an important role in KSHV-mediated PROX1 upregulation. We found that PROX1 mRNA contains a canonical AU-rich element (ARE) in its 3′-untranslated region that promotes PROX1 mRNA turnover and that kaposin-B stimulates cytoplasmic accumulation of the ARE-binding protein HuR through activation of the p38/MK2 pathway. Moreover, HuR binds to and stabilizes PROX1 mRNA through its ARE and is necessary for KSHV-mediated PROX1 mRNA stabilization. Together, our study demonstrates that kaposin-B plays a key role in PROX1 upregulation during lymphatic reprogramming of blood vascular endothelial cells by KSHV.
Zdroje
1. ChangY
CesarmanE
PessinMS
LeeF
CulpepperJ
1994
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science
266
1865
1869
2. MemarOM
RadyPL
TyringSK
1995
Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions.
J Mol Med
73
603
609
3. OrfanosCE
HusakR
WolferU
GarbeC
1995
Kaposi's sarcoma: a reevaluation.
Recent Results Cancer Res
139
275
296
4. RutgersJL
WieczorekR
BonettiF
KaplanKL
PosnettDN
1986
The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.
Am J Pathol
122
493
499
5. NadimiH
SaateeS
ArminA
TotoPD
1988
Expression of endothelial cell markers PAL-E and EN-4 and Ia-antigens in Kaposi's sarcoma.
J Oral Pathol
17
416
420
6. KraffertC
PlanusL
PenneysNS
1991
Kaposi's sarcoma: further immunohistologic evidence of a vascular endothelial origin.
Arch Dermatol
127
1734
1735
7. MiettinenM
LindenmayerAE
ChaubalA
1994
Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens—evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Mod Pathol
7
82
90
8. UcciniS
RucoLP
MonardoF
StoppacciaroA
DejanaE
1994
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.
J Pathol
173
23
31
9. ZhangYM
BachmannS
HemmerC
van LunzenJ
von StemmA
1994
Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.
Am J Pathol
144
51
59
10. PammerJ
PlettenbergA
WeningerW
DillerB
MildnerM
1996
CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
Am J Pathol
148
1387
1396
11. BecksteadJH
WoodGS
FletcherV
1985
Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.
Am J Pathol
119
294
300
12. JussilaL
ValtolaR
PartanenTA
SalvenP
HeikkilaP
1998
Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
Cancer Res
58
1599
1604
13. Breiteneder-GeleffS
SoleimanA
KowalskiH
HorvatR
AmannG
1999
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Am J Pathol
154
385
394
14. MarchioS
PrimoL
PaganoM
PalestroG
AlbiniA
1999
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
J Biol Chem
274
27617
27622
15. MarconciniL
MarchioS
MorbidelliL
CartocciE
AlbiniA
1999
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
Proc Natl Acad Sci U S A
96
9671
9676
16. SkobeM
BrownLF
TognazziK
GanjuRK
DezubeBJ
1999
Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
J Invest Dermatol
113
1047
1053
17. WeningerW
PartanenTA
Breiteneder-GeleffS
MayerC
KowalskiH
1999
Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Lab Invest
79
243
251
18. FolpeAL
VeikkolaT
ValtolaR
WeissSW
2000
Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Mod Pathol
13
180
185
19. KahnHJ
BaileyD
MarksA
2002
Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Mod Pathol
15
434
440
20. HongYK
ForemanK
ShinJW
HirakawaS
CurryCL
2004
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.
Nat Genet
36
683
685
21. WangHW
TrotterMW
LagosD
BourbouliaD
HendersonS
2004
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
Nat Genet
36
687
693
22. CarrollPA
BrazeauE
LagunoffM
2004
Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.
Virology
328
7
18
23. SivakumarR
Sharma-WaliaN
RaghuH
VeettilMV
SadagopanS
2008
Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications.
J Virol
82
1759
1776
24. WigleJT
HarveyN
DetmarM
LagutinaI
GrosveldG
2002
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.
EMBO J
21
1505
1513
25. WigleJT
OliverG
1999
Prox1 function is required for the development of the murine lymphatic system.
Cell
98
769
778
26. Sosa-PinedaB
WigleJT
OliverG
2000
Hepatocyte migration during liver development requires Prox1.
Nat Genet
25
254
255
27. YangY
CveklA
2005
Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter.
J Mol Biol
351
453
469
28. WigleJT
ChowdhuryK
GrussP
OliverG
1999
Prox1 function is crucial for mouse lens-fibre elongation.
Nat Genet
21
318
322
29. PistocchiA
GaudenziG
CarraS
BrescianiE
Del GiaccoL
2008
Crucial role of zebrafish prox1 in hypothalamic catecholaminergic neurons development.
BMC Dev Biol
8
27
30. MisraK
GuiH
MatiseMP
2008
Prox1 regulates a transitory state for interneuron neurogenesis in the spinal cord.
Dev Dyn
237
393
402
31. SteinerB
ZurborgS
HorsterH
FabelK
KempermannG
2008
Differential 24 h responsiveness of Prox1-expressing precursor cells in adult hippocampal neurogenesis to physical activity, environmental enrichment, and kainic acid-induced seizures.
Neuroscience
154
521
529
32. LavadoA
OliverG
2007
Prox1 expression patterns in the developing and adult murine brain.
Dev Dyn
236
518
524
33. DabdoubA
PuligillaC
JonesJM
FritzschB
CheahKS
2008
Sox2 signaling in prosensory domain specification and subsequent hair cell differentiation in the developing cochlea.
Proc Natl Acad Sci U S A
105
18396
18401
34. NicholsDH
PauleyS
JahanI
BeiselKW
MillenKJ
2008
Lmx1a is required for segregation of sensory epithelia and normal ear histogenesis and morphogenesis.
Cell Tissue Res
334
339
358
35. KirjavainenA
SulgM
HeydF
AlitaloK
Yla-HerttualaS
2008
Prox1 interacts with Atoh1 and Gfi1, and regulates cellular differentiation in the inner ear sensory epithelia.
Dev Biol
322
33
45
36. Bermingham-McDonoghO
OesterleEC
StoneJS
HumeCR
HuynhHM
2006
Expression of Prox1 during mouse cochlear development.
J Comp Neurol
496
172
186
37. GillHK
ParsonsSR
SpallutoC
DaviesAF
KnorzVJ
2009
Separation of the PROX1 gene from upstream conserved elements in a complex inversion/translocation patient with hypoplastic left heart.
Eur J Hum Genet
38. RisebroCA
SearlesRG
MelvilleAA
EhlerE
JinaN
2009
Prox1 maintains muscle structure and growth in the developing heart.
Development
136
495
505
39. PetrovaTV
MakinenT
MakelaTP
SaarelaJ
VirtanenI
2002
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.
EMBO J
21
4593
4599
40. HongYK
HarveyN
NohYH
SchachtV
HirakawaS
2002
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.
Dev Dyn
225
351
357
41. FanXC
MyerVE
SteitzJA
1997
AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation.
Genes Dev
11
2557
2568
42. MyerVE
FanXC
SteitzJA
1997
Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay.
Embo J
16
2130
2139
43. BarreauC
PaillardL
OsborneHB
2005
AU-rich elements and associated factors: are there unifying principles?
Nucleic Acids Res
33
7138
7150
44. KhabarKS
2005
The AU-rich transcriptome: more than interferons and cytokines, and its role in disease.
J Interferon Cytokine Res
25
1
10
45. GaestelM
2006
MAPKAP kinases - MKs - two's company, three's a crowd.
Nat Rev Mol Cell Biol
7
120
130
46. TranH
MaurerF
NagamineY
2003
Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Mol Cell Biol
23
7177
7188
47. DeanJL
SullyG
ClarkAR
SaklatvalaJ
2004
The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.
Cell Signal
16
1113
1121
48. DeanJL
WaitR
MahtaniKR
SullyG
ClarkAR
2001
The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR.
Mol Cell Biol
21
721
730
49. LevyNS
ChungS
FurneauxH
LevyAP
1998
Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR.
J Biol Chem
273
6417
6423
50. PengSS
ChenCY
XuN
ShyuAB
1998
RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein.
Embo J
17
3461
3470
51. WangW
CaldwellMC
LinS
FurneauxH
GorospeM
2000
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.
Embo J
19
2340
2350
52. WangW
FurneauxH
ChengH
CaldwellMC
HutterD
2000
HuR regulates p21 mRNA stabilization by UV light.
Mol Cell Biol
20
760
769
53. FordLP
WatsonJ
KeeneJD
WiluszJ
1999
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.
Genes Dev
13
188
201
54. FanXC
SteitzJA
1998
Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.
Embo J
17
3448
3460
55. YamanI
FernandezJ
SarkarB
SchneiderRJ
SniderMD
2002
Nutritional control of mRNA stability is mediated by a conserved AU-rich element that binds the cytoplasmic shuttling protein HuR.
J Biol Chem
277
41539
41546
56. FanXC
SteitzJA
1998
HNS, a nuclear-cytoplasmic shuttling sequence in HuR.
Proc Natl Acad Sci U S A
95
15293
15298
57. McCormickC
GanemD
2005
The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.
Science
307
739
741
58. McCormickC
GanemD
2006
Phosphorylation and function of the kaposin B direct repeats of Kaposi's sarcoma-associated herpesvirus.
J Virol
80
6165
6170
59. MorrisVA
PunjabiAS
LagunoffM
2008
Activation of Akt through gp130 receptor signaling is required for KSHV induced lymphatic reprogramming of endothelial cells.
J Virol
60. ZinovievaRD
DuncanMK
JohnsonTR
TorresR
PolymeropoulosMH
1996
Structure and chromosomal localization of the human homeobox gene Prox 1.
Genomics
35
517
522
61. TomarevSI
ZinovievaRD
ChangB
HawesNL
1998
Characterization of the mouse Prox1 gene.
Biochem Biophys Res Commun
248
684
689
62. SteffensenKR
HolterE
BavnerA
NilssonM
Pelto-HuikkoM
2004
Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue.
EMBO Rep
5
613
619
63. HinrichsAS
KarolchikD
BaertschR
BarberGP
BejeranoG
2006
The UCSC Genome Browser Database: update 2006.
Nucleic Acids Res
34
D590
598
64. ChenCY
XuN
ShyuAB
1995
mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation.
Mol Cell Biol
15
5777
5788
65. ChenCY
ShyuAB
2003
Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway.
Mol Cell Biol
23
4805
4813
66. MasudaK
AbdelmohsenK
GorospeM
2009
RNA-binding proteins implicated in the hypoxic response.
J Cell Mol Med
67. NaborsLB
GillespieGY
HarkinsL
KingPH
2001
HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs.
Cancer Res
61
2154
2161
68. Lopez de SilanesI
ZhanM
LalA
YangX
GorospeM
2004
Identification of a target RNA motif for RNA-binding protein HuR.
Proc Natl Acad Sci U S A
101
2987
2992
69. AnantS
HouchenCW
2009
HuR and TTP: two RNA binding proteins that deliver message from the 3′ end.
Gastroenterology
136
1495
1498
70. LafargaV
CuadradoA
Lopez de SilanesI
BengoecheaR
Fernandez-CapetilloO
2009
p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint.
Mol Cell Biol
29
4341
4351
71. WangS
ZhangJ
ZhangY
KernS
DannerRL
2008
Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and -independent mechanisms.
J Leukoc Biol
83
982
990
72. JinSH
KimTI
YangKM
KimWH
2007
Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR.
Eur J Pharmacol
558
14
20
73. NeiningerA
KontoyiannisD
KotlyarovA
WinzenR
EckertR
2002
MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.
J Biol Chem
277
3065
3068
74. DayanAD
LewisPD
1967
Origin of Kaposi's sarcoma from the reticulo-endothelial system.
Nature
213
889
890
75. AguilarB
HongYK
2009
PantanowitzL
StebbingJ
DezubeBJ
The origin of Kaposi sarcoma tumor cells
Research Signpost
123
138
76. Di BartoloDL
CannonM
LiuYF
RenneR
ChadburnA
2008
KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor.
Blood
111
4731
4740
77. OkaM
IwataC
SuzukiHI
KiyonoK
MorishitaY
2008
Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis.
Blood
111
4571
4579
78. EnsoliB
SirianniMC
1998
Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology.
Crit Rev Oncog
9
107
124
79. HerndierB
GanemD
2001
The biology of Kaposi's sarcoma.
Cancer Treat Res
104
89
126
80. PantanowitzL
DezubeBJ
2004
Advances in the pathobiology and treatment of Kaposi sarcoma.
Curr Opin Oncol
16
443
449
81. DouglasJL
GustinJK
DezubeB
PantanowitzJL
MosesAV
2007
Kaposi's sarcoma: a model of both malignancy and chronic inflammation.
Panminerva Med
49
119
138
82. SadlerR
WuL
ForghaniB
RenneR
ZhongW
1999
A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.
J Virol
73
5722
5730
83. ZhongW
WangH
HerndierB
GanemD
1996
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.
Proc Natl Acad Sci U S A
93
6641
6646
84. StaskusKA
ZhongW
GebhardK
HerndierB
WangH
1997
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.
J Virol
71
715
719
85. DadrasSS
SkrzypekA
NguyenL
ShinJW
SchulzMM
2008
Prox-1 Promotes Invasion of Kaposiform Hemangioendotheliomas.
J Invest Dermatol
86. PetrovaTV
NykanenA
NorrmenC
IvanovKI
AnderssonLC
2008
Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
Cancer Cell
13
407
419
87. TakahashiM
YoshimotoT
ShimodaM
KonoT
KoizumiM
2006
Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells.
Neoplasia
8
1003
1010
88. NagaiH
LiY
HatanoS
ToshihitoO
YugeM
2003
Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
Genes Chromosomes Cancer
38
13
21
89. DudasJ
MansurogluT
MoriconiF
HallerF
WiltingJ
2008
Altered regulation of Prox1-gene-expression in liver tumors.
BMC Cancer
8
92
90. QinJ
ZhaiJ
HongR
ShanS
KongY
2009
Prospero-related homeobox protein (Prox1) inhibits hepatitis B virus replication through repressing multiple cis regulatory elements.
J Gen Virol
90
1246
1255
91. YoshimotoT
TakahashiM
NagayamaS
WatanabeG
ShimadaY
2007
RNA mutations of prox1 detected in human esophageal cancer cells by the shifted termination assay.
Biochem Biophys Res Commun
359
258
262
92. VersmoldB
FelsbergJ
MikeskaT
EhrentrautD
KohlerJ
2007
Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Int J Cancer
121
547
554
93. KamiyaA
KakinumaS
OnoderaM
MiyajimaA
NakauchiH
2008
Prospero-related homeobox 1 and liver receptor homolog 1 coordinately regulate long-term proliferation of murine fetal hepatoblasts.
Hepatology
48
252
264
94. FlisterMJ
WilberA
HallKL
IwataC
MiyazonoK
2009
Inflammation induces lymphangiogenesis through upregulation of VEGFR-3 mediated by NF-{kappa}B and Prox1.
Blood
95. LeeS
KangJ
YooJ
GanesanSK
CookSC
2009
Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate.
Blood
113
1856
1859
96. TenenbaumSA
LagerPJ
CarsonCC
KeeneJD
2002
Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.
Methods
26
191
198
97. Cohen-TannoudjiM
MorelloD
BabinetC
1992
Unexpected position-dependent expression of H-2 and beta 2-microglobulin/lacZ transgenes.
Mol Reprod Dev
33
149
159
98. ShinJW
MinM
Larrieu-LahargueF
CanronX
KunstfeldR
2006
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Mol Biol Cell
17
576
584
99. Essafi-BenkhadirK
OnestoC
StebeE
MoroniC
PagesG
2007
Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.
Mol Biol Cell
18
4648
4658
100. LevyAP
LevyNS
GoldbergMA
1996
Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.
J Biol Chem
271
2746
2753
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- The Transcription Factor Rbf1 Is the Master Regulator for -Mating Type Controlled Pathogenic Development in
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia